Birdwatch Note Rating
2023-03-17 03:26:56 UTC - HELPFUL
Rated by Participant: 02DA8945EBB14B39E32EADC27A9147BF8D2811DBF8590C258E92374C9C3580D5
Participant Details
Original Note:
From a GAO report on mifepristone: "FDA approved the drug under a provision of the agency’s Subpart H regulations … titled “Accelerated Approval of New Drugs". The regulation "provides FDA with flexibilities that allow the agency to accelerate the approval process" https://www.gao.gov/assets/gao-08-751.pdf
All Note Details